Holdings
Soleus Capital Management, L.P.
As of Jun 30, 2026, Soleus Capital Management, L.P. reported 83 positions worth US$2.5B. Largest: Krystal Biotech, Inc., Celcuity Inc. and Tg Therapeutics, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Krystal Biotech, Inc. | 939K | US$349M | −214K | Jun 30, 2026 |
| Celcuity Inc. | 1.7M | US$178M | +420K | Jun 30, 2026 |
| Tg Therapeutics, Inc. | 2.93M | US$161M | −1.1M | Jun 30, 2026 |
| Insulet Corporation | 1.05M | US$160M | +487K | Jun 30, 2026 |
| United Therapeutics Corporation | 226K | US$122M | +38,400 | Jun 30, 2026 |
| Inspire Medical Systems, Inc. | 1.93M | US$86.2M | +1.36M | Jun 30, 2026 |
| Rigel Pharmaceuticals, Inc. | 1.84M | US$72.1M | +1.83M | Jun 30, 2026 |
| Ani Pharmaceuticals, Inc. | 868K | US$71.8M | +47,517 | Jun 30, 2026 |
| Beta Bionics, Inc. | 4.39M | US$68.8M | +39,213 | Jun 30, 2026 |
| Vericel Corporation | 1.46M | US$64.9M | −1.09M | Jun 30, 2026 |